Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pertuzumab in Indian Patients with HER2+ Advanced Breast Cancer
NCT02445586Phase 4Completed
- Sponsor
- Roche
- Start
- Aug 2015
- Primary completion
- Sep 2018
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of pertuzumab in breast cancer, sponsored by Roche. Started Aug 2015; status: completed.
02
Drugs
pertuzumab
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02445586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02445586.